Search Results 1621-1630 of 15616 for sunwin.men

1. Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations - Mayo Clinic

   Both females and male subjects with female partners of child-bearing potential must agree to use a highly effective method of contraception for 2 weeks ...

2. A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer - Mayo Clinic

   While on study drug and for 3 months following the last dose of study drug, a male subject must agree to use an adequate contraception method as deemed ...

3. A Study to Evaluate Lung Function in Subjects with Idiopathic Pulmonary Fibrosis (IPF) After Taking BI 1015550 for 12 Weeks - Mayo Clinic

   Inability to refrain from smoking on trial days. Male patients who do not agree to minimize the risk of female partners becoming pregnant from first dosing ...

4. CLEOPATTRA: A Research Study To Look At The Effects Of Treatment With A Medicine Called Coramitug (NNC6019-0001) In People With Heart Failure Due To Transthyretin Amyloid (ATTR) Amyloidosis - Mayo Clinic

   Male or female. Age 18 years or above at the time of signing the informed consent. Have an established diagnosis of ATTR-CM (wild-type ATTR [ATTRwt] or ...

5. Ibrutinib and Ixazomib Citrate in Treating Participants With Relapsed or Refractory Waldenstrom Macroglobulinemia - Mayo Clinic

   Participation eligibility · Pregnant women; · Nursing women; · Men or women of child bearing potential (WCBP) who are unwilling to employ effective contraception.

6. Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

   Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; Patents ...

7. A Study to Evaluate Encorafenib Plus Cetuximab with/without Chemotherapy to Treat Metastatic Colorectal Cancer - Mayo Clinic

   - Safety Lead-In = Male/female ≥ 18 years old - Phase 3 and Cohort 3: Male/female ≥ 16 years old (where permitted locally) - Histologically or ...

8. Clinical trials - Oncology (Medical)

   This protocol is being designed to offer testicular tissue cryopreservation to male pediatric patients (0-17 years of age) with fertility threatening ...

9. MediCool Protocol - Mayo Clinic

   Male or female. Subject has documented paroxysmal, or persistent atrial fibrillation (AF) with a history of less than one-year duration. Must be in AF at ...

10. Clinical trials - Oncology (Medical)

    Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...